ITERETGENE PARVEC
UNII 78XF2E5BJ6

Substance Identification & Data

This profile provides standardized clinical and technical data for Iteretgene Parvec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 78XF2E5BJ6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2964417-31-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
78XF2E5BJ6
CAS Registry Number
2964417-31-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ITERETGENE PARVEC
Official standardized name for this substance within the FDA UNII nomenclature system.
INN ID
13812
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Iteretgene Parvec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ITERETGENE PARVEC

Common Names & Synonyms

ITERETGENE PARVEC (RECOMBINANT NON-REPLICATING ADENO-ASSOCIATED VIRUS SEROTYPE 2 (RAAV2) VECTOR ENCODING CODON-OPTIMISED HUMAN RETINAL PIGMENT EPITHELIUM-SPECIFIC 65 KDA PROTEIN (RPE65; RETINOID ISOMEROHYDROLASE) UNDER CONTROL OF THE HUMAN UBIQUITIN C PROMOTER AND A CHIMERIC HUMAN UBIQUITIN C/RABBIT .BETA.-GLOBIN INTRON, AND A HUMAN GROWTH HORMONE POLYADENYLATION SIGNAL; FLANKED BY AAV2 INVERTED TERMINAL REPEATS (ITRS))
ITERETGENE PARVEC [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record